The California Board of Pharmacy inspected 578 sterile compounding pharmacies in hospital and community settings in a span of 3 months. Their report of these findings presented some basic points regarding violations.
Because this represents a large portion of California's sterile compounding pharmacies, ITL Consulting has re-tabulated the same data to detect further trends for the purpose of citing practical data during the revision period of California's sterile compounding regulations. This report takes a detailed look at the findings, provides a brief analysis, and lists recent legislative initiatives in other states.